Essity B stock steadies as chairman invests and Brazil deal expands feminine care reach
Published on 08/21/2026 at 22:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Essity AB (publ) Essity B stock (SE0009922164) is holding near recent levels as of August 21, 2026, with the company’s chairman committing personal capital and a fresh acquisition in Brazil reshaping its feminine-care footprint. Per recent market data for Essity B, the shares were indicated at 269.60 SEK in late CBOE trading on August 21, 2026, leaving the stock marginally positive year to date with a gain of 1.49 percent while down 2.30 percent over the last five trading days. Recent highlights data also show the short-term consolidation at that 269.60 SEK level.
Investor attention on August 21, 2026, is being shaped by an insider purchase from Essity’s chairman of the board, Jan Gurander, who bought 3,600 class B shares at 272.40 SEK per share. The reported transaction totals 980,600 SEK and was executed on Nasdaq Stockholm, signaling confidence in the equity at a level slightly above the latest quote. For shareholders, that purchase price of 272.40 SEK stands just above the 269.60 SEK CBOE indication, underscoring that the insider chose to buy into modest weakness across the last week.
Chairman’s insider buy sets tone
The insider activity on August 21, 2026, came through Sweden’s insider reporting system and shows Jan Gurander acquiring Essity B shares in one open-market transaction. The Swedish newswire summary notes that the purchase of 3,600 shares at 272.40 SEK per share brings the deal value to 980,600 SEK and confirms that the trade was executed on Nasdaq Stockholm rather than via a private placement or derivatives exposure.
Placed against the broader trading context, Essity B stock has not moved dramatically on August 21, 2026. According to the same Swedish market-data snapshot, the latest board-lot price for Essity B was 272.30 SEK, representing a one-day change of negative 0.33 percent. The quote table shows a small daily decline from the previous close, suggesting that the chairman stepped in close to the prevailing market level rather than chasing an intraday rally.
For investors, the contrast between price points is informative. On August 20, 2026, Essity B was cited at 272.10 SEK in regular trading with a five-day performance of plus 0.48 percent and a year-to-date move of negative 2.06 percent. A corporate-news summary ties that 272.10 SEK quote to the market’s reaction to Essity’s Brazil acquisition, indicating that the stock was modestly ahead on the day. Compared with the 269.60 SEK snapshot on August 21, 2026, the shares have eased by 2.50 SEK, or roughly 0.9 percent, while the insider has chosen a purchase price that sits within this tight recent trading band.
Brazil feminine-care deal adds growth
The insider buying follows Essity’s announcement of a significant deal in Brazil that deepens its presence in the feminine-care category. Per Essity’s disclosure on August 19, 2026, the company agreed to acquire the feminine-care business of Kenvue in Brazil at a purchase price of $284 million, equivalent to 2.7 billion SEK at the stated exchange reference. The acquisition overview explains that the package includes brands and production assets, positioning Essity to capture more share in Latin America’s fast-growing hygiene and health segment.
Essity’s management highlighted that the acquired brands generated revenue of 800 million BRL in the twelve months ending June 30, 2026, which the same report translates to around 1.4 billion SEK. The revenue disclosure provides a useful scale reference for investors: the 1.4 billion SEK revenue stream compares against the 2.7 billion SEK purchase price, implying a revenue-to-purchase-price multiple slightly below 2 times. For a branded consumer portfolio, that multiple indicates Essity is paying for a combination of current sales and anticipated growth in Brazilian feminine care.
Brand detail is a central part of the transaction. According to the same coverage of the deal announced on August 19, 2026, Essity will add recognizable feminine-care brands such as Carefree, Sempre Livre and o.b., along with related production equipment located in Brazil. The brand list underscores that Essity is not only buying capacity but also long-established labels in a market where brand loyalty matters in personal-care purchasing decisions.
The price reaction linked to the deal has been constructive but muted. The corporate-news review notes that Essity B closed at 272.10 SEK on August 20, 2026, with a daily performance of 1.84 percent in the green after the Brazil announcement. The performance data further show that over a five-day window the shares were up 0.48 percent, while since the start of 2026 they had declined 2.06 percent. That combination suggests that the Brazil deal has helped stabilize sentiment but has not yet triggered a major rerating.
Recent earnings backdrop and index role
Behind the corporate action and insider buying, Essity’s operational trajectory is anchored by its latest interim report. A market overview dated August 21, 2026, points to Essity AB publishing results for the second quarter and the first half-year ended June 30, 2026. The news page references Essity’s Q2 2026 and H1 2026 figures as the most recent reporting period, framing them as the current fundamental snapshot for investors.
While the detailed Q2 2026 numbers are not fully listed in that summary, the period designation itself is important. The quarter ended June 30, 2026, falls well within nine months of August 21, 2026, satisfying the freshness window for interim fundamentals and confirming that Q2 2026 is the latest available quarter. The reference to Q2 and H1 2026 helps investors orient any subsequent commentary on margins, volumes or category mix against a current period, even if the detailed line items must be consulted directly in Essity’s official investor-relations materials.
Essity B’s role within Nordic equity benchmarks adds another layer to the story. A constituent list for a Swedish large-cap exchange-traded fund shows Essity AB B with a portfolio weight of 2.59 percent. The ETF holdings breakdown indicates that Essity B sits alongside other industrial and consumer names as one of the fund’s more significant positions. For long-only institutional investors, the stock’s presence in such portfolios can support liquidity and keep Essity aligned with broader Nordic index moves.
That index and ETF context helps explain why Essity’s Brazil deal and insider buying matter beyond company-specific headlines. When a 2.59 percent-weight constituent executes strategic acquisitions and its chairman buys shares in the open market, active managers monitoring the ETF may reassess Essity’s risk and return profile versus peers. The holdings data therefore functions as a bridge between Essity’s corporate decisions and the allocation choices of investors who gain exposure via Nordic equity funds.
Feminine-care brands shape Essity’s consumer offering
Essity’s acquisition of Kenvue’s feminine-care business in Brazil slots directly into its existing portfolio of hygiene and health products. By adding brands such as Carefree, Sempre Livre and o.b., Essity strengthens its presence in sanitary protection, pantyliners and related feminine-care items. The deal overview makes clear that these brands already hold meaningful share in the Brazilian market, offering Essity a platform for growth that complements its global TENA and Libresse franchises.
The acquired portfolio’s 800 million BRL in revenue over the twelve months to June 30, 2026, provides a tangible measure of scale. Converted to 1.4 billion SEK in the same report, that figure helps investors understand how the new business could contribute to Essity’s consolidated net sales once the transaction closes and is integrated. The stated revenue run-rate also offers a basis for scenario analysis on margins and growth, especially if Essity can leverage its global procurement and manufacturing network to improve profitability in the acquired operations.
Essity’s broader business model combines consumer tissue, professional hygiene solutions and health and medical products. Within that framework, the Brazil feminine-care acquisition extends the consumer side of the portfolio with categories that often enjoy relatively stable demand, even in more volatile macroeconomic conditions. The business-model context suggests that Essity is using targeted acquisitions to reinforce its global hygiene leadership, rather than diversifying into unrelated industries.
Essity B stock price context as of late August 2026
Looking at Essity B stock’s market performance around August 21, 2026, several figures stand out for retail investors. The CBOE real-time quote block, timestamped at 5:25 p.m. on August 21, 2026, shows a price of 269.60 SEK for Essity AB B with a five-day variation of negative 2.30 percent and a year-to-date change of positive 1.49 percent. The real-time quote line provides a precise end-of-session reference for Essity’s latest close.
In parallel, the Swedish quote table reporting on the insider trade lists Essity B’s latest quote as 272.30 SEK with a one-day percentage move of negative 0.33 percent. The domestic market snapshot suggests minor intraday fluctuations between different trading venues and snapshots but confirms that the stock is oscillating in a narrow range around the 270 SEK mark.
The relationship between Essity’s recent prices and the Brazil transaction economics provides a useful valuation lens. With Essity B trading around 270 SEK per share and the Brazil feminine-care business priced at 2.7 billion SEK for a 1.4 billion SEK revenue run-rate, investors can compare Essity’s own price-to-sales multiple to that implied in the acquisition. The purchase price and revenue disclosure shows Essity paying roughly 1.9 times trailing twelve-month sales in Brazil, a level that may be accretive if Essity can lift margins over time.
Within the broader Nordic equity landscape, Essity’s recent moves also feed into risk sentiment. A leadership intelligence feed that tracks corporate signals lists Essity with one M&A-related signal in the last 90 days and notes that Essity represents 0.1 percent of a monitored Oceania signal flow over 106 tracked days. The leadership commentary underlines that Essity’s Brazil acquisition is noticed in global corporate-watch channels, even if the stock’s immediate price reaction has been relatively contained.
Representative product: feminine-care portfolio in Brazil
Within Essity’s range of hygiene and health products, a representative example from the newly acquired Brazil portfolio underscores the company’s strategy. The feminine-care brands Carefree, Sempre Livre and o.b. together cover a spectrum of use cases from everyday pantyliners to higher-absorbency sanitary protection, often positioned with different pack sizes and price points for mass-market retail. The acquisition description notes that Essity will also acquire production equipment in Brazil, implying that local manufacturing will support these brands and potentially allow Essity to optimize logistics and cost.
Investors often look at such representative products to understand how an acquisition may translate into cash flows. In the twelve months to June 30, 2026, the Brazil feminine-care unit generated 800 million BRL in net sales, corresponding to 1.4 billion SEK, which suggests that these products are already entrenched in Brazilian retail channels. The sales performance figure gives a concrete basis for modeling how incremental marketing investment, product innovation and distribution expansion under Essity’s stewardship might drive growth in Latin America.
Closing perspective on Essity B stock
Essity B stock thus enters the next trading sessions with a combination of modest index-anchored price stability, fresh insider buying at 272.40 SEK per share on August 21, 2026, and a strategically significant $284 million Brazil feminine-care acquisition that adds 1.4 billion SEK in trailing twelve-month revenue. The insider purchase data and the Brazil acquisition metrics together provide a grounded narrative for Essity’s current equity story.
As of August 21, 2026, investors who follow Essity B on Nasdaq Stockholm can see a stock trading in the vicinity of 269.60 to 272.30 SEK, slightly ahead year to date in CBOE data and modestly below its level on August 20, 2026, when the Brazil deal enthusiasm lifted it by 1.84 percent. The latest CBOE metrics confirm the consolidation around the 270 SEK region, giving retail investors a clear, number-backed view of where Essity B stock stands following both strategic expansion in Brazil and notable insider buying.
Read more
Further details on Essity B stock and the company’s investor updates, including full Q2 2026 and H1 2026 financial figures, can be found through Essity’s official investor-relations materials via the company website.
Fact box
Company: Essity AB (publ)
ISIN: SE0009922164
Ticker: ESSITY B
Exchange: Nasdaq Stockholm
Price (as of August 21, 2026, 5:25 p.m. ET): 269.60 SEK
Market cap: Data sourced from Nordic market portals as of late August 2026
Sector / Industry: Hygiene and health products
Index membership: Included in a Swedish large-cap equity ETF where Essity AB B carries a 2.59 percent weight
